EP1373306A4 - Cytoskelett assoziierte proteine - Google Patents

Cytoskelett assoziierte proteine

Info

Publication number: EP1373306A4
Authority: EP; European Patent Office
Prior art keywords: cytoskeletion; associated proteins; proteins
Prior art date: 2001-03-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP02757814A

Other languages

English (en)

French (fr)

Other versions

EP1373306A2 (de

Inventor

April J A Hafalia

Tom Y Tang

Henry Yue

Farrah A Khan

Craig H Ison

Mariah R Baughn

Bridget A Warren

Brendan M Duggan

Kavitha Thangavelu

Cynthia D Honchell

Yalda Azimzai

Vicki S Elliott

Neil Burford

Li Ding

Huibin Yue

Shanya Becha

Brooke M Emerling

Thomas W Richardson

Soo Yeun Lee

Olga Bandman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Incyte Corp

Original Assignee

Incyte Genomics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-29

Filing date

2002-03-25

Publication date

2005-07-20

2002-03-25 Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc

2004-01-02 Publication of EP1373306A2 publication Critical patent/EP1373306A2/de

2005-07-20 Publication of EP1373306A4 publication Critical patent/EP1373306A4/de

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Toxicology (AREA)
Zoology (AREA)
Oncology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Pain & Pain Management (AREA)
Proteomics, Peptides & Aminoacids (AREA)

EP02757814A 2001-03-29 2002-03-25 Cytoskelett assoziierte proteine Withdrawn EP1373306A4 (de)

Applications Claiming Priority (15)

Application Number	Priority Date	Filing Date	Title
US28050801P	2001-03-29	2001-03-29
US280508P		2001-03-29
US28132301P	2001-04-03	2001-04-03
US281323P		2001-04-03
US28376901P	2001-04-13	2001-04-13
US283769P		2001-04-13
US28860901P	2001-05-04	2001-05-04
US288609P		2001-05-04
US29051801P	2001-05-10	2001-05-10
US290518P		2001-05-10
US29187001P	2001-05-18	2001-05-18
US291870P		2001-05-18
US29445101P	2001-05-29	2001-05-29
US294451P		2001-05-29
PCT/US2002/009288 WO2002079404A2 (en)	2001-03-29	2002-03-25	Cytoskeleton-associated proteins

Publications (2)

Publication Number	Publication Date
EP1373306A2 EP1373306A2 (de)	2004-01-02
EP1373306A4 true EP1373306A4 (de)	2005-07-20

Family

ID=27569565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP02757814A Withdrawn EP1373306A4 (de)	2001-03-29	2002-03-25	Cytoskelett assoziierte proteine

Country Status (5)

Country	Link
EP (1)	EP1373306A4 (de)
JP (1)	JP2004533227A (de)
AU (1)	AU2002306879A1 (de)
CA (1)	CA2441654A1 (de)
WO (1)	WO2002079404A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050085627A1 (en)	2001-06-21	2005-04-21	Youming Zhang	Atopy
AU2003228872A1 (en) *	2002-05-10	2003-11-11	Incyte Corporation	Cell adhesion and extracellular matrix proteins

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000017355A2 (en) *	1998-09-18	2000-03-30	Incyte Pharmaceuticals, Inc.	Human cytoskeleton associated proteins
WO2000056883A1 (en) *	1999-03-23	2000-09-28	Human Genome Sciences, Inc.	49 human secreted proteins
WO2002068579A2 (en) *	2001-01-10	2002-09-06	Pe Corporation (Ny)	Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof

2002
- 2002-03-25 EP EP02757814A patent/EP1373306A4/de not_active Withdrawn
- 2002-03-25 WO PCT/US2002/009288 patent/WO2002079404A2/en not_active Application Discontinuation
- 2002-03-25 CA CA002441654A patent/CA2441654A1/en not_active Abandoned
- 2002-03-25 JP JP2002578407A patent/JP2004533227A/ja active Pending
- 2002-03-25 AU AU2002306879A patent/AU2002306879A1/en not_active Abandoned

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000017355A2 (en) *	1998-09-18	2000-03-30	Incyte Pharmaceuticals, Inc.	Human cytoskeleton associated proteins
WO2000056883A1 (en) *	1999-03-23	2000-09-28	Human Genome Sciences, Inc.	49 human secreted proteins
WO2002068579A2 (en) *	2001-01-10	2002-09-06	Pe Corporation (Ny)	Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BERNAL S D ET AL: "CYTOSKELETON-ASSOCIATED PROTEINS THEIR ROLE AS CELLULAR INTEGRATORS IN THE NEOPLASTIC PROCESS", CRITICAL REVIEWS IN ONCOLOGY-HEMATOLOGY, vol. 3, no. 3, 1985, pages 191 - 204, XP009042995, ISSN: 1040-8428 *
DATABASE EM_PAT 3 February 2004 (2004-02-03), "Sequence 21262 from Patent WO02068579", XP002314716, retrieved from EBI Database accession no. CQ735328 *
SATO H ET AL: "The Genomic Organization of Type I Keratin Genes in Mice", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 56, no. 3, 15 March 1999 (1999-03-15), pages 303 - 309, XP004444979, ISSN: 0888-7543 *

Also Published As

Publication number	Publication date
JP2004533227A (ja)	2004-11-04
WO2002079404A2 (en)	2002-10-10
EP1373306A2 (de)	2004-01-02
WO2002079404A3 (en)	2003-03-20
CA2441654A1 (en)	2002-10-10
AU2002306879A1 (en)	2002-10-15

Publication	Publication Date	Title
GB0130228D0 (en)	2002-02-06	Protein
EP1365022A4 (de)	2004-04-28	Adiponectin-assoziiertes protein
GB0130557D0 (en)	2002-02-06	Proteins
GB0108079D0 (en)	2001-05-23	Protein
GB0130720D0 (en)	2002-02-06	Proteins
EP1437410A4 (de)	2005-01-26	Neue selenocystein enthaltende proteine
EP1373306A4 (de)	2005-07-20	Cytoskelett assoziierte proteine
GB0130560D0 (en)	2002-02-06	Proteins
AU2002326909A8 (en)	2006-11-02	Neurotransmission-associated proteins
GB0106318D0 (en)	2001-05-02	Protein
GB0130721D0 (en)	2002-02-06	Protein
GB0100750D0 (en)	2001-02-21	Novel proteins
GB0111303D0 (en)	2001-06-27	Proteins
GB0130739D0 (en)	2002-02-06	Proteins
GB0120557D0 (en)	2001-10-17	Proteins
GB0108895D0 (en)	2001-05-30	Proteins
GB0125514D0 (en)	2001-12-12	Proteins
GB0130742D0 (en)	2002-02-06	Proteins
GB0130743D0 (en)	2002-02-06	Proteins
GB0108472D0 (en)	2001-05-23	Proteins
GB0126787D0 (en)	2002-01-02	Proteins
GB0114313D0 (en)	2001-08-01	Proteins
GB0128374D0 (en)	2002-01-16	Proteins
GB0130722D0 (en)	2002-02-06	Proteins
GB0128487D0 (en)	2002-01-23	Proteins

Legal Events

Date	Code	Title	Description
2003-11-14	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2004-01-02	17P	Request for examination filed	Effective date: 20030916
2004-01-02	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2004-01-02	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2005-07-20	A4	Supplementary search report drawn up and despatched	Effective date: 20050603
2005-08-05	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
2005-09-21	18W	Application withdrawn	Effective date: 20050728
2007-08-08	RIN1	Information on inventor provided before grant (corrected)	Inventor name: JONES, KAREN ANNE Inventor name: RING, HUIJUN Z. Inventor name: SWARNAKAR, ANITA Inventor name: LEE, ERNESTINE A. Inventor name: GRIFFIN, JENNIFER A. Inventor name: CHAWLA, NARINDER K. Inventor name: GIETZEN, KIMBERLY J. Inventor name: LEE, SALLY Inventor name: LAL, PREETI G. Inventor name: BANDMAN, OLGA Inventor name: LEE, SOO, YEUN Inventor name: RICHARDSON, THOMAS, W. Inventor name: EMERLING, BROOKE, M. Inventor name: BECHA, SHANYA Inventor name: YUE, HUIBIN Inventor name: DING, LI Inventor name: BURFORD, NEIL Inventor name: ELLIOTT, VICKI, S. Inventor name: AZIMZAI, YALDA Inventor name: HONCHELL, CYNTHIA, D. Inventor name: THANGAVELU, KAVITHA Inventor name: DUGGAN, BRENDAN, M. Inventor name: WARREN, BRIDGET, A. Inventor name: BAUGHN, MARIAH, R. Inventor name: ISON, CRAIG, H. Inventor name: KHAN, FARRAH, A. Inventor name: YUE, HENRY Inventor name: TANG, TOM, Y. Inventor name: HAFALIA, APRIL, J., A.